Pola Orbis Holdings Inc. (TYO:4927)
Japan · Delayed Price · Currency is JPY 1,406.00
0.00 (0.00%)
Aug 21, 2026, 3:30 PM JST
Pola Orbis Holdings Revenue
Pola Orbis Holdings had revenue of 43.52B JPY in the quarter ending June 30, 2026, with 3.77% growth. This brings the company's revenue in the last twelve months to 171.38B, up 0.95% year-over-year. In the year 2025, Pola Orbis Holdings had annual revenue of 170.29B, down -0.04%.
Revenue (ttm)
171.38B
Revenue Growth
+0.95%
P/S Ratio
1.82
Revenue / Employee
43.97M
Employees
3,898
Market Cap
311.12B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 170.29B | -74.00M | -0.04% |
| Dec 31, 2024 | 170.36B | -2.95B | -1.70% |
| Dec 31, 2023 | 173.30B | 7.00B | 4.21% |
| Dec 31, 2022 | 166.31B | -12.34B | -6.90% |
| Dec 31, 2021 | 178.64B | 2.33B | 1.32% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Lion Corporation | 439.47B |
| Rohto Pharmaceutical | 353.39B |
| KOSE Holdings | 334.58B |
| Cawachi | 285.45B |
| Genky DrugStores | 220.64B |
| Earth | 185.57B |
| Kobayashi Pharmaceutical | 167.47B |
| MTG Co., Ltd. | 131.24B |
Pola Orbis Holdings News
- 14 days ago - Pola Orbis Holdings Quarterly report: Q2 2026 - Filings
- 14 days ago - Pola Orbis Holdings Slides: Q2 2026 - Filings